Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Goebeler, M.
	Articles by Klein, C. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Goebeler, M.
	Articles by Klein, C. E.


Social Bookmarking

	What's this?

Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B. and Seed, B (1990). CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 1303-1313.[Medline]

Bartolazzi, A., Peach, R., Aruffo, A. and Stamenkovic, I (1994). Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med 180, 53-66.[Abstract/Free Full Text]

Bazil, V. and Horejsi, V (1992). Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. J. Immunol 149, 747-753.[Abstract]

Bazil, V. and Strominger, J. L (1994). Metalloprotease and serine protease are involved in cleavage of CD43, CD44 and CD16 from stimulated human granulocytes. J. Immunol 152, 1314-1322.[Abstract]

Brown, T. A., Bouchard, T., St. John, T., Wayner, E. and Carter, W. G (1991). Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sufate intrinsic membrane proteoglycan with additional exons. J. Cell. Biol 113, 207-221.[Abstract/Free Full Text]

Culty, M., Miyake, K., Kincade, P. W., Silorski, E., Butcher, E. C. and Underhill, C (1990). The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J. Cell Biol 111, 2765-2774.[Abstract/Free Full Text]

Culty, M., Shizari, M., Thompson, E. W. and Underhill, C. B (1994). Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J. Cell. Physiol 160, 275-286.[Medline]

Danen, E. H. J., van Muijen, G. N. P., Wiel van de Kemenade, E., Jansen, K. F. J., Ruiter, D. J. and Figdor, C. G (1993). Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells. Int. J. Cancer 54, 315-321.[Medline]

Flanagan, B. F., Dalchau, R., Allen, A. K., Daar, A. S. and Fabre, J. W (1989). Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunology 67, 167-175.[Medline]

Gallatin, M. W., Wayner, E. A., Hoffman, P. A., St. John, T., Butcher, E. C. and Carter, W. G (1989). Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc. Nat. Acad. Sci. USA 86, 4654-4658.[Abstract/Free Full Text]

Goebeler, M., Meinardus-Hager, G., Roth, J., Goerdt, S. and Sorg, C (1993). Nickel chloride and cobalt chloride, two common contact sensitizers, directly induce expression of ICAM-1, VCAM-1 and ELAM-1 by endothelial cells. J. Invest. Dermatol 100, 759-765.[Medline]

Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Z\232ller, M., Haussmann,I., Matzku, S., Wenzel, A., Ponta,H. and Herrlich, P (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65, 13-14.[Medline]

Guo, Y., Ma, J., Wang, J., Che, X., Narula, J., Bigby, M., Wu, M. and Sy, M. S (1994). Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54, 1561-1565.[Abstract/Free Full Text]

Halaban, R., Gosh, S., Duray, P., Kirkwood, J. M. and Lerner, A. B (1986). Human melanocytes cultured from nevi and melanomas. J. Invest. Dermatol 87, 95-101.[Medline]

Hardwick, C., Hoare, K., Owens, R., Hohn, H. P., Hook, M., Moore, D., Cripps, V., Austen, L., Nance, D. M. and Turley, E. A (1992). Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J. Cell Biol 117, 1343-1350.[Abstract/Free Full Text]

Hart, I. R., Birch, M. and Marshall, J. F (1991). Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metast. Rev 10, 115-128.[Medline]

Haynes, B. F., Liao, H. X. and Patton, K. L (1991). The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cell 3, 347-350.[Medline]

Herrlich, P., Z\232ller, M., Pals, S. T. and Ponta, H (1993). CD44 splice variants: metastases meet lymphocytes. Immunol. Today 14, 395-399.[Medline]

Hofmann, M., Rudy, W., Z\232ller, M., Tolg, C., Ponta, H., Herrlich, P. and Gunthert, U (1991). CD44 splice variants confer metastatic behaviour in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51, 5292-5297.[Abstract/Free Full Text]

Jalkanen, S., Bargatze, R. F., Herron, L. R. and Butcher, E. C (1986). A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur. J. Immunol 16, 1195-1202.[Medline]

Jalkanen, S., Bargatze, R. F., del los Toyos, J. and Butcher, E. C (1987). Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells. J. Cell Biol 105, 983-900.[Abstract/Free Full Text]

Jalkanen, S., Jalkanen, M., Bargatze, R., Tammi, M. and Butcher, E. C (1988). Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol 141, 1615-1623.[Abstract]

Katoh, S., McCarthy, J. B. and Kincade, P. W (1994). Characterization of soluble CD44 in the circulation of mice. J. Immunol 153, 3440-3449.[Abstract]

Katoh, S., Zheng, Z., Oritani, K., Shimozato, T. and Kincade, P. W (1995). Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med 182, 419-429.[Abstract/Free Full Text]

Klein, C. E., Cordon-Cordo, C., Soehnchen, R., Eote, R. J., Oettgen, H. F., Eisinger, M. and Old, L. J (1987). Changes in cell surface glycoprotein expression during differentiation of human keratinocytes. J. Invest. Dermatol 89, 500-506.[Medline]

Klein, C. E., Ozer, H., Traganos, F., Atzpodien, J., Oettgen, H. and Old, L. J (1988). A transformation-associated 130-kD cell surface glycoprotein is growth-controlled in normal human cells. J. Exp. Med 167, 1684-1696.[Abstract/Free Full Text]

Knudson, C. B. and Knudson, W (1993). Hyaluronan-binding proteins in development, tissue homeostasis and disease. FASEB J 7, 1233-1241.[Abstract]

Lesley, J., Hyman, R. and Kincade, P. W (1993). CD44 and its interaction with the extracellular matrix. Adv. Immunol 54, 271-335.[Medline]

Lesley, J., English, N., Perschl, A., Gregoroff, J. and Hyman, R (1995). Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med 182, 431-437.[Abstract/Free Full Text]

Mackay, C. R., Maddox, J. F., Wijffels, G. L., Mackay, I. R. and Walker, I. D (1988). Characterization of a 95000 molecule on sheep leukocytes homologous to murine Pgp-1 and human CD44. Immunology 65, 93-99.[Medline]

Miyake, K., Underhill, C. B., Lesley, J. and Kincade, P. W (1990). Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med 172, 69-75.[Abstract/Free Full Text]

Murakami, S., Shimabukuro, Y., Miki, Y., Saho, T., Hino, E., Kasai, D., Nozaki, T., Kosomoto, Y. and Okada, H (1994). Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J. Immunol 152, 467-477.[Abstract]

Pals, S. T., Hogervorst, F., Keizer, G. D., Thepen, T., Horst, E. and Figdor, C. C (1989). Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor. J. Immunol 143, 851-857.[Abstract]

Peach, R. J., Hollenbaugh, D., Stamenkovic, I. and Aruffo, A (1993). Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol 122, 257-264.[Abstract/Free Full Text]

Pure, E., Camp, R. L., Peritt, D., Panettieri, R. A., Lazaar, A. L. and Nayak, S (1995). Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med 181, 55-62.[Abstract/Free Full Text]

Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U. and Bell, J. I (1992). Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Nat. Acad. Sci. USA 89, 12160-12164.[Abstract/Free Full Text]

Sherman, L., Sleeman, J., Herrlich, P. and Ponta, H (1994). Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell. Biol 6, 726-733.[Medline]

Stamenkovic, I., Amiot, M., Pesando, J. M. and Seed, B (1989). A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link family. Cell 56, 1057-1062.[Medline]

Stamenkovic, I., Aruffo, A., Amiot, M. and Seed, B (1991). The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10, 343-348.[Medline]

Sy, M. S., Guo, Y. J. and Stamenkovic, I (1991). Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med 174, 859-866.[Abstract/Free Full Text]

Thomas, L., Byers, H. R., Vink, J. and Stamenkovic, I (1992). CD44H regulates tumor cell migration on hyaluronate-coated substrates. J. Cell Biol 118, 971-977.[Abstract/Free Full Text]

Thomas, L., Etoh, T., Stamenkovic, I., Mihm, M. C. and Byers, H. R (1993). Migration of human melanoma cells on hyaluronate is related to CD44 expression. J. Invest. Dermatol 100, 115-120.[Medline]

Tilgen, W., Boukamp, P., Breitkreutz, D., Dzarlieva, R. T., Engstner, M., Haag, D. and Fusenig, N. E (1983). Preservation of morphological, functional and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. Cancer Res 43, 5995-6011.[Abstract/Free Full Text]

Turley, E. A. and Tretiak, M (1984). Glycosaminoglycans produced by murine melanoma variants in vivo and in vitro. Cancer Res 45, 5098-5105.[Abstract/Free Full Text]

Turley, E. A., Tretiak, M. and Tanguay, K (1987). Effect of glycosaminoglycans and enzymes on the integrity of human placental amnion as a barrier to cell invasion. J. Nat. Cancer Inst 78, 787-795.

Turley, E. A (1992). Hyaluronan and cell locomotion. Cancer Metast. Rev 11, 21-30.[Medline]

Underhill, C (1992). CD44: The hyaluronan receptor. J. Cell Sci 103, 293-298.[Medline]

van Muijen, G. N. P., Cornelissen, L. M. H. A., Jansen, C. F. J. and Ruiter, D. J (1989). Progression markers in metastasizing human melanoma cells xenografted to nude mice. Anticancer Res 9, 879-884.[Medline]

van Muijen, G. N. P., Jansen, C. F. J., Cornelissen, L. M. H. A., Beck, J. L. M. and Ruiter, D. J (1991). Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int. J. Cancer 48, 85-91.[Medline]

van Muijen, G. N. P., Danen, E. H., Veerkamp, E. H., Ruiter, D. J., Lesley, J. and van den Heuvel, L. P (1995). Glycokonjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int. J. Cancer 61, 241-248.[Medline]

Versteeg, R., Noordermeer, I. O. A., Kruse-Wolters, M., Ruiter, D. J. and Schrier, P. I (1988). C-myc down-regulates class I HLA expression in human melanomas. EMBO J 7, 1023-1029.[Medline]

Yang, B., Yang, B. L., Savani, R. C. and Turley, E. A (1994). Identification of a common hyaluronate binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 13, 286-296.[Medline]

Zheng, Z., Katoh, S., He, Q., Oritani, K., Miyake, K., Lesley, J., Hyman, R., Hamik, A., Parkhouse, R. M. E., Farr, A. G. and Kincade, P (1995). Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol 130, 485-495.[Abstract/Free Full Text]

Z\232ller, M. and Kaufmann, M (1994). CD44 and metastasis. Onkologie 17, 114-122.

Zwadlo, G., Voegeli, R., Schulze Osthoff, K. and Sorg, C (1987). A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp. Cell. Biol 55, 295-304.[Medline]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

S. R. Hamilton, S. F. Fard, F. F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J. B. McCarthy, M. J. Bissell, J. Koropatnick, and E. A. Turley
The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells
J. Biol. Chem., June 1, 2007; 282(22): 16667 - 16680.
[Abstract] [Full Text] [PDF]

L. Pelletier, P. Guillaumot, B. Freche, C. Luquain, D. Christiansen, S. Brugiere, J. Garin, and S. N. Manie
{gamma}-Secretase-Dependent Proteolysis of CD44 Promotes Neoplastic Transformation of Rat Fibroblastic Cells.
Cancer Res., April 1, 2006; 66(7): 3681 - 3687.
[Abstract] [Full Text] [PDF]

H. Nakamura, N. Suenaga, K. Taniwaki, H. Matsuki, K. Yonezawa, M. Fujii, Y. Okada, and M. Seiki
Constitutive and Induced CD44 Shedding by ADAM-Like Proteases and Membrane-Type 1 Matrix Metalloproteinase
Cancer Res., February 1, 2004; 64(3): 876 - 882.
[Abstract] [Full Text] [PDF]

H. Matsuki, K. Yonezawa, K.'i. Obata, K. Iwata, H. Nakamura, Y. Okada, and M. Seiki
Monoclonal Antibodies with Defined Recognition Sequences in the Stem Region of CD44: Detection of Differential Glycosylation of CD44 between Tumor and Stromal Cells in Tissue
Cancer Res., December 1, 2003; 63(23): 8278 - 8283.
[Abstract] [Full Text] [PDF]

I. Gal, J. Lesley, W. Ko, A. Gonda, R. Stoop, R. Hyman, and K. Mikecz
Role of the Extracellular and Cytoplasmic Domains of CD44 in the Rolling Interaction of Lymphoid Cells with Hyaluronan under Physiologic Flow
J. Biol. Chem., March 21, 2003; 278(13): 11150 - 11158.
[Abstract] [Full Text] [PDF]

M. Kajita, Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinoh, and M. Seiki
Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration
J. Cell Biol., May 28, 2001; 153(5): 893 - 904.
[Abstract] [Full Text] [PDF]

S.-H. Leir, J. E. Baker, S. T. Holgate, and P. M. Lackie
Increased CD44 expression in human bronchial epithelial repair after damage or plating at low cell densities
Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1129 - L1137.
[Abstract] [Full Text] [PDF]

K. Maaser, K. Wolf, C. E. Klein, B. Niggemann, K. S. Zänker, E.-B. Bröcker, and P. Friedl
Functional Hierarchy of Simultaneously Expressed Adhesion Receptors: Integrin alpha 2beta 1 but Not CD44 Mediates MV3 Melanoma Cell Migration and Matrix Reorganization within Three-dimensional Hyaluronan-containing Collagen Matrices
Mol. Biol. Cell, October 1, 1999; 10(10): 3067 - 3079.
[Abstract] [Full Text]

I. Okamoto, Y. Kawano, M. Matsumoto, M. Suga, K. Kaibuchi, M. Ando, and H. Saya
Regulated CD44 Cleavage under the Control of Protein Kinase C, Calcium Influx, and the Rho Family of Small G Proteins
J. Biol. Chem., September 3, 1999; 274(36): 25525 - 25534.
[Abstract] [Full Text] [PDF]

I. M. S. Dahl, I. Turesson, E. Holmberg, and K. Lilja
Serum Hyaluronan in Patients With Multiple Myeloma: Correlation With Survival and Ig Concentration
Blood, June 15, 1999; 93(12): 4144 - 4148.
[Abstract] [Full Text] [PDF]

W Hayen, M Goebeler, S Kumar, R Riessen, and V Nehls
Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture
J. Cell Sci., January 7, 1999; 112(13): 2241 - 2251.
[Abstract] [PDF]

D Peck and C. Isacke
Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325
J. Cell Sci., January 6, 1998; 111(11): 1595 - 1601.
[Abstract] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Goebeler, M.

Articles by Klein, C. E.

Search for Related Content

PubMed

PubMed Citation

Articles by Goebeler, M.

Articles by Klein, C. E.

Social Bookmarking

What's this?

				L. Pelletier, P. Guillaumot, B. Freche, C. Luquain, D. Christiansen, S. Brugiere, J. Garin, and S. N. Manie {gamma}-Secretase-Dependent Proteolysis of CD44 Promotes Neoplastic Transformation of Rat Fibroblastic Cells. Cancer Res., April 1, 2006; 66(7): 3681 - 3687. [Abstract] [Full Text] [PDF]

				H. Nakamura, N. Suenaga, K. Taniwaki, H. Matsuki, K. Yonezawa, M. Fujii, Y. Okada, and M. Seiki Constitutive and Induced CD44 Shedding by ADAM-Like Proteases and Membrane-Type 1 Matrix Metalloproteinase Cancer Res., February 1, 2004; 64(3): 876 - 882. [Abstract] [Full Text] [PDF]

				H. Matsuki, K. Yonezawa, K.'i. Obata, K. Iwata, H. Nakamura, Y. Okada, and M. Seiki Monoclonal Antibodies with Defined Recognition Sequences in the Stem Region of CD44: Detection of Differential Glycosylation of CD44 between Tumor and Stromal Cells in Tissue Cancer Res., December 1, 2003; 63(23): 8278 - 8283. [Abstract] [Full Text] [PDF]

				I. Gal, J. Lesley, W. Ko, A. Gonda, R. Stoop, R. Hyman, and K. Mikecz Role of the Extracellular and Cytoplasmic Domains of CD44 in the Rolling Interaction of Lymphoid Cells with Hyaluronan under Physiologic Flow J. Biol. Chem., March 21, 2003; 278(13): 11150 - 11158. [Abstract] [Full Text] [PDF]

				M. Kajita, Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinoh, and M. Seiki Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration J. Cell Biol., May 28, 2001; 153(5): 893 - 904. [Abstract] [Full Text] [PDF]

				S.-H. Leir, J. E. Baker, S. T. Holgate, and P. M. Lackie Increased CD44 expression in human bronchial epithelial repair after damage or plating at low cell densities Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1129 - L1137. [Abstract] [Full Text] [PDF]

				K. Maaser, K. Wolf, C. E. Klein, B. Niggemann, K. S. Zänker, E.-B. Bröcker, and P. Friedl Functional Hierarchy of Simultaneously Expressed Adhesion Receptors: Integrin alpha 2beta 1 but Not CD44 Mediates MV3 Melanoma Cell Migration and Matrix Reorganization within Three-dimensional Hyaluronan-containing Collagen Matrices Mol. Biol. Cell, October 1, 1999; 10(10): 3067 - 3079. [Abstract] [Full Text]

				I. Okamoto, Y. Kawano, M. Matsumoto, M. Suga, K. Kaibuchi, M. Ando, and H. Saya Regulated CD44 Cleavage under the Control of Protein Kinase C, Calcium Influx, and the Rho Family of Small G Proteins J. Biol. Chem., September 3, 1999; 274(36): 25525 - 25534. [Abstract] [Full Text] [PDF]

				I. M. S. Dahl, I. Turesson, E. Holmberg, and K. Lilja Serum Hyaluronan in Patients With Multiple Myeloma: Correlation With Survival and Ig Concentration Blood, June 15, 1999; 93(12): 4144 - 4148. [Abstract] [Full Text] [PDF]

				W Hayen, M Goebeler, S Kumar, R Riessen, and V Nehls Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture J. Cell Sci., January 7, 1999; 112(13): 2241 - 2251. [Abstract] [PDF]

				D Peck and C. Isacke Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325 J. Cell Sci., January 6, 1998; 111(11): 1595 - 1601. [Abstract] [PDF]